Skip to main content

Table 4 Correlation between MiR-130b and patient clinicopathological characteristics

From: RETRACTED ARTICLE: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis

Items

MiR-130b (N = 91)

p

Low (N = 46)

High (N = 45)

 

Gender

  

0.929

 

Male

19

19

 
 

Female

27

26

 

Smoking Status

  

0.303

 

Nonsmoker

12

7

 
 

Smoker

34

38

 

Tumor Location

  

0.327

 

Central

21

16

 
 

Peripheral

25

29

 

Differentiation

  

0.002

 

High

31

16

 
 

Moderate-Poor

15

29

 

LN Metastasis

  

0.026

 

Yes

33

22

 
 

No

13

23

 

Tumor Size

  

0.002

 

>3 cm

36

21

 
 

<3 cm

10

24

 

TNM Stage

  

0.025

 

I-II

25

14

 
 

III-IV

21

31

 
  1. p values listed are derived from χ2 test